Cidara Therapeutics, Inc.·4

Sep 3, 4:32 PM ET

Shah Preetam 4

4 · Cidara Therapeutics, Inc. · Filed Sep 3, 2021

Insider Transaction Report

Form 4
Period: 2021-09-01
Shah Preetam
CFO & CBO
Transactions
  • Award

    Restricted Stock Unit

    2021-09-01+50,00050,000 total
    Exp: 2022-09-30Common Stock (50,000 underlying)
  • Award

    Stock Option (right to buy)

    2021-09-01+311,850311,850 total
    Exercise: $2.22Exp: 2031-08-31Common Stock (311,850 underlying)
Footnotes (3)
  • [F1]25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of September 1, 2021; 1/48th of the shares subject to the option shall vest monthly thereafter,such that all shares will be vested on September 1, 2025.
  • [F2]Restricted stock units convert into common stock on a one-for-one basis.
  • [F3]The RSU will fully vest upon the completion of certain corporate milestones on or before September 30, 2022.

Documents

1 file
  • 4
    wf-form4_163070111456972.xmlPrimary

    FORM 4